|
gptkbp:instanceOf
|
Controlled substance classification
|
|
gptkbp:abuseMayLeadTo
|
severe psychological or physical dependence
|
|
gptkbp:cannotBePrescribedByFaxOrPhone
|
except in emergencies
|
|
gptkbp:comparedToScheduleI
|
lower abuse potential
|
|
gptkbp:comparedToScheduleIII
|
higher abuse potential
|
|
gptkbp:definedIn
|
gptkb:United_States_federal_law
|
|
gptkbp:example
|
gptkb:oxycodone
gptkb:morphine
gptkb:secobarbital
gptkb:methylphenidate
cocaine
amphetamine
hydrocodone
fentanyl
|
|
gptkbp:haveAcceptedMedicalUse
|
true
|
|
gptkbp:haveHighPotentialForAbuse
|
true
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Schedule II drugs
|
|
gptkbp:partOf
|
gptkb:Controlled_Substances_Act_(United_States)
|
|
gptkbp:prescribingRestrictions
|
strict
|
|
gptkbp:prescriptionRequired
|
true
|
|
gptkbp:recordKeepingRequired
|
true
|
|
gptkbp:refillsAllowed
|
false
|
|
gptkbp:regulates
|
gptkb:Drug_Enforcement_Administration
|
|
gptkbp:scheduleNumber
|
II
|
|
gptkbp:storage
|
secure
|
|
gptkbp:subject
|
state and federal regulations
|
|
gptkbp:bfsParent
|
gptkb:Title_II:_Controlled_Substances_Act
gptkb:Controlled_Substances_Act_(US)
|
|
gptkbp:bfsLayer
|
7
|